Tadocizumab

Tax included
Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
HY-P99560

Data sheet

Size
Multiple sizes
Reactivity
Integrin
CAS
339086-80-5